Cargando…

Serum soluble ST2 is associated with ER-positive breast cancer

BACKGROUND: ST2, a member of the interleukin (IL)-1receptor family, regulates Th1/Th2 immune responses in autoimmune and inflammatory conditions. However, the role of ST2 signaling in tumor growth and metastasis of breast cancers has not been investigated. This study investigated the possible role o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Da-peng, Zhou, Xiang-yu, Yao, Lu-tian, Liu, Cai-gang, Ma, Wei, Jin, Feng, Wu, Yun-fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995159/ https://www.ncbi.nlm.nih.gov/pubmed/24636276 http://dx.doi.org/10.1186/1471-2407-14-198

Ejemplares similares

Correlation between serum lipid levels and endocrine resistance in patients with ER-positive breast cancer
por: Sun, Hong, et al.
Publicado: (2023)

Prognostic role of serum soluble ST2 of advanced breast cancer patients: a retrospective cohort study
por: Chen, Chong, et al.
Publicado: (2023)

Elevated Serum Levels of Soluble ST2 Are Associated With Plaque Vulnerability in Patients With Non-ST-Elevation Acute Coronary Syndrome
por: Luo, Guqing, et al.
Publicado: (2021)

Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients
por: Farcaş, Anca Daniela, et al.
Publicado: (2017)

AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
por: Zhou, Meng, et al.
Publicado: (2023)

Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure
por: Wang, Zeyu, et al.
Publicado: (2022)

Soluble ST2 in serum predicts the prognosis of idiopathic pulmonary fibrosis: a retrospective study
por: Yu, Yan-Zhe, et al.
Publicado: (2022)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Super-enhancer-controlled positive feedback loop BRD4/ERα–RET–ERα promotes ERα-positive breast cancer
por: Zheng, Zao-zao, et al.
Publicado: (2022)

ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells
por: Deng, Hao, et al.
Publicado: (2014)

Serum Soluble ST2 and Adverse Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction
por: Kercheva, Maria, et al.
Publicado: (2019)

Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer
por: Shi, Liang, et al.
Publicado: (2015)

Although c-MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER-positive breast cancer
por: Chen, Rui, et al.
Publicado: (2020)

Systematic identification of Ctr9 regulome in ERα-positive breast cancer
por: Zeng, Hao, et al.
Publicado: (2016)

Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis
por: Wang, Jin, et al.
Publicado: (2022)

The Association of Serum IL-33 and sST2 with Breast Cancer
por: Yang, Zhi-Ping, et al.
Publicado: (2015)

An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
por: Zhou, Xin, et al.
Publicado: (2014)

Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines
por: Shen, Kui, et al.
Publicado: (2012)

Elastosis in ERα-positive male breast cancer
por: Vermeulen, Marijn A., et al.
Publicado: (2020)

COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR
por: Lu, Renquan, et al.
Publicado: (2016)

Early cardiopulmonary resuscitation on serum levels of myeloperoxidase, soluble ST2, and hypersensitive C-reactive protein in acute myocardial infarction patients
por: Hou, Min, et al.
Publicado: (2021)

Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer
por: Su, Peng, et al.
Publicado: (2014)

A Positive Feedback Loop of ER-α36/EGFR Promotes Malignant Growth of ER-negative Breast Cancer Cells
por: Zhang, XianTian, et al.
Publicado: (2010)

Apoptosis/Necrosis Induction by Ultraviolet, in ER Positive and ER Negative Breast Cancer Cell Lines
por: Shokrollahi Barough, Mahdieh, et al.
Publicado: (2015)

Positive association between heart dosimetry parameters and a novel cardiac biomarker, solubleST‐2, in thoracic cancer chest radiation
por: Zeng, Zhi‐min, et al.
Publicado: (2020)

HAS2-Ezrin-ER axis plays a role in acquired antiestrogen resistance of ER-positive breast cancer
por: Sun, Xiaodan, et al.
Publicado: (2022)

The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer
por: Liu, Shu-Shu, et al.
Publicado: (2020)

Are Soluble ST2 Levels in the Picogram or Nanogram Range in Serum of Healthy Subjects/Disease Patients?
por: Saluja, Rohit
Publicado: (2014)

Prognostic Significance of High Expression of ER-beta in Surgically Treated ER-Positive Breast Cancer Following Endocrine Therapy
por: Kim, Tae-Jung, et al.
Publicado: (2012)

Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis
por: Gao, Hong-Fei, et al.
Publicado: (2020)

Andrographolide Inhibits ER-Positive Breast Cancer Growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-α Axis
por: Xu, Tong, et al.
Publicado: (2022)

The integrative epigenomic-transcriptomic landscape of ER positive breast cancer
por: Gao, Yang, et al.
Publicado: (2015)

The prognostic effects of somatic mutations in ER-positive breast cancer
por: Griffith, Obi L., et al.
Publicado: (2018)

RCC2 Expression Stimulates ER-Positive Breast Tumorigenesis
por: Wang, Weiqi, et al.
Publicado: (2020)

Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
por: Alomran, Reem, et al.
Publicado: (2021)

Expression profile analysis of long noncoding RNA in ER-positive subtype breast cancer using microarray technique and bioinformatics
por: Peng, Jing, et al.
Publicado: (2017)

Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation
por: Wang, Zefeng, et al.
Publicado: (2020)

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
por: Groenendijk, Floris H., et al.
Publicado: (2019)

Isolation and Characterization of a Metastatic Hybrid Cell Line Generated by ER Negative and ER Positive Breast Cancer Cells in Mouse Bone Marrow
por: Mukhopadhyay, Keya De, et al.
Publicado: (2011)

Serum Level of Interleukin-33 and Soluble ST2 and Their Association with Disease Activity in Patients with Behcet's Disease
por: Kim, Dae-Jun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f4t7m69l142b0qr9rchjpglg23